GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients [Meeting Abstract]

dc.authoridKilickap, Saadettin/0000-0003-1637-7390
dc.authoridTurna, Hande/0000-0003-0558-9371
dc.authoridPaydas, Semra/0000-0003-4642-3693
dc.authoridBeypınar, İsmail/0000-0002-0853-4096;
dc.authorwosidCoşkun, Hasan Şenol/C-2070-2016
dc.authorwosidKilickap, Saadettin/AAP-3732-2021
dc.authorwosidTurna, Hande/AAA-2972-2020
dc.authorwosidPaydas, Semra/F-3132-2018
dc.authorwosidAYDIN, Kubra/ABG-5437-2022
dc.authorwosidBeypınar, İsmail/AAN-1107-2020
dc.authorwosidNg, Terry/AEX-1224-2022
dc.contributor.authorPeled, N.
dc.contributor.authorGillis, R.
dc.contributor.authorKilickap, S.
dc.contributor.authorFroesch, P.
dc.contributor.authorOrlov, S.
dc.contributor.authorFilippova, E.
dc.contributor.authorDemirci, U.
dc.date.accessioned2024-06-12T11:13:44Z
dc.date.available2024-06-12T11:13:44Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpageS656en_US
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue3en_US
dc.identifier.startpageS656en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/23671
dc.identifier.volume16en_US
dc.identifier.wosWOS:000631349602018en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal Of Thoracic Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectROS1(+)en_US
dc.subjectALK(+)en_US
dc.subjectLorlatiniben_US
dc.titleGLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients [Meeting Abstract]en_US
dc.typeConference Objecten_US

Dosyalar